What is NDC 75907-224?

75907-224 is the product NDC for Abiraterone Acetate, Abiraterone acetate 250 mg/1 tablet, listed with the FDA by Dr. Reddys Laboratories Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Dr. Reddys Laboratories Inc, NDC labeler code 75907. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Abiraterone Acetate?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Abiraterone Acetate NDC 75907-224 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)75907-224Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75907-0224Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75907-224-04	7590702240475907022404	120 TABLET in 1 BOTTLE (75907-224-04)Marketed from Mar 17, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Abiraterone Acetate
Generic name (nonproprietary): abiraterone acetate
Active ingredients: Abiraterone acetate — 250 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Dr. Reddys Laboratories IncNDC labeler code 75907
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208416
Marketing start: Mar 17, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 17A1 Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)
Identifiers: Product ID 75907-224_6c96e35d-9099-e164-0960-353b01420f81SPL ID 6c96e35d-9099-e164-0960-353b01420f81SPL set ID 0c91aa38-3b0a-232c-8eb1-55f08e8e6644RxCUI 1100075UNII EM5OCB9YJ6
Pharmacologic class: Cytochrome P450 17A1 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475907022404 followed by a unit qualifier and the quantity

Package 75907-0224-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2025.

Indications (excerpt from the label)

Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablet is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). ( 1) metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 75907-224

What is NDC 75907-224?: 75907-224 is the product NDC for Abiraterone Acetate, Abiraterone acetate 250 mg/1 tablet, listed with the FDA by Dr. Reddys Laboratories Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Abiraterone Acetate.
What is the active ingredient?: Abiraterone acetate.
Who is the labeler?: Dr. Reddys Laboratories Inc, NDC labeler code 75907. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Abiraterone Acetate?: 28 other product NDCs are listed under this name. See all Abiraterone Acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Abiraterone Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Abiraterone Acetate	Abiraterone acetate 250 mg/1	TabletOral	AvPAK	50268-032	50268-0032-12
Abiraterone Acetateabiraterone	Abiraterone acetate 250 mg/1	TabletOral	American Health Packaging	60687-790	60687-0790-21
Abiraterone Acetate	Abiraterone acetate 500 mg/1	TabletOral	Dr. Reddys Laboratories Inc	43598-468	43598-0468-3843598-0468-60
Abiraterone Acetateabiraterone	Abiraterone acetate 250 mg/1	TabletOral	Amneal Pharmaceuticals LLC	60219-1165	60219-1165-07
Abiraterone Acetateabiraterone	Abiraterone acetate 500 mg/1	TabletOral	Amneal Pharmaceuticals LLC	60219-1754	60219-1754-06
Abiraterone acetate	Abiraterone acetate 500 mg/1	Tablet, Film coatedOral	Florida Pharmaceutical Products, LLC	71921-177	71921-0177-06
abiraterone acetate	Abiraterone acetate 250 mg/1	TabletOral	Florida Pharmaceutical Products, LLC.	71921-178	71921-0178-20
abiraterone acetate	Abiraterone acetate 500 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-882	68462-0882-60
abiraterone acetate	Abiraterone acetate 500 mg/1	TabletOral	NORTHSTAR RX LLC	72603-111	72603-0111-01
abiraterone acetate	Abiraterone acetate 250 mg/1	TabletOral	NORTHSTAR RX LLC	72603-110	72603-0110-01

All 29 Abiraterone Acetate NDCs

Other NDCs under ANDA 208416

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208416
Product	Strength	Form · route	Labeler	Product NDC
Abiraterone Acetate	Abiraterone acetate 250 mg/1	TabletOral	NorthStar Rx LLC	16714-963
Abiraterone Acetate	Abiraterone acetate 250 mg/1	TabletOral	Dr. Reddys Laboratories Inc	43598-358
Abiraterone Acetate	Abiraterone acetate 500 mg/1	TabletOral	Dr. Reddys Laboratories Inc	43598-468
Abiraterone Acetate	Abiraterone acetate 250 mg/1	TabletOral	AvPAK	50268-032